Junyi Xu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Vorinostat Potentiates Chemoimmunotherapy in Immune-Enriched Pancreatic Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 01, 2025
LY6D identifies persistent stem-like cells driving pancreatic tumourigenesis.
Journal: Gut
Published: July 23, 2025
ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer.
Journal: Gastroenterology
Published: March 27, 2025
Deciphering fatty acid biosynthesis-driven molecular subtypes in pancreatic ductal adenocarcinoma with prognostic insights.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: April 23, 2024
MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer.
Journal: Gut
Published: March 07, 2024
SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 02, 2024
Clostridium butyricum and its metabolite butyrate promote ferroptosis susceptibility in pancreatic ductal adenocarcinoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 15, 2023
Spatiotemporal role of SETD2-H3K36me3 in murine pancreatic organogenesis.
Journal: Cell reports
Published: January 04, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026